| Title |
Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment
|
|---|---|
| Published in |
Clinical Pharmacokinetics, March 2019
|
| DOI | 10.1007/s40262-019-00754-4 |
| Pubmed ID | |
| Authors |
Christian Rolfo, Judith de Vos-Geelen, Nicolas Isambert, L. Rhoda Molife, Jan H. M. Schellens, Jacques De Grève, Luc Dirix, Peter Grundtvig-Sørensen, Guy Jerusalem, Karin Leunen, Morten Mau-Sørensen, Ruth Plummer, Maria Learoyd, Wendy Bannister, Anitra Fielding, Alain Ravaud |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 2 | 13% |
| United States | 2 | 13% |
| Japan | 2 | 13% |
| United Kingdom | 1 | 7% |
| Colombia | 1 | 7% |
| Sweden | 1 | 7% |
| France | 1 | 7% |
| Spain | 1 | 7% |
| Unknown | 4 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 53% |
| Practitioners (doctors, other healthcare professionals) | 3 | 20% |
| Science communicators (journalists, bloggers, editors) | 2 | 13% |
| Scientists | 2 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 39 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 6 | 15% |
| Professor | 3 | 8% |
| Lecturer | 2 | 5% |
| Student > Bachelor | 2 | 5% |
| Student > Postgraduate | 2 | 5% |
| Other | 6 | 15% |
| Unknown | 18 | 46% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 26% |
| Nursing and Health Professions | 4 | 10% |
| Business, Management and Accounting | 3 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Psychology | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 18 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 August 2023.
All research outputs
#4,885,559
of 24,076,257 outputs
Outputs from Clinical Pharmacokinetics
#294
of 1,549 outputs
Outputs of similar age
#99,683
of 356,483 outputs
Outputs of similar age from Clinical Pharmacokinetics
#4
of 17 outputs
Altmetric has tracked 24,076,257 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,549 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,483 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.